Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LEO Plays Up Rapid Action Of Picato For Actinic Keratosis

This article was originally published in The Pink Sheet Daily

Executive Summary

Newly approved plant-based gel works in just a few days of treatment, rather than the weeks required for some competitors.

Advertisement

Related Content

New Irritable Bowel Disease And Burn Therapies Among Those Recommended By Europe’s CHMP
CDER Approvals In January Came Early And Often
NME Candidates For 2012 Have Modest Ambitions; Standard Reviews And Small Molecules Dominate
NME Candidates For 2012 Have Modest Ambitions; Standard Reviews And Small Molecules Dominate
Medicis Plans To Build On Zyclara After Graceway Acquisition
Skin Tight: Dermatology Specialty Leo Pharma To Buy Peplin for $287.5 Million

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS073307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel